Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices

Biomaterials

Volumn 17, Issue 5, 1996, Pages 471-484

  Jayakrishnan, A ^a   Jameela, S R ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Bioprostheses; Glutaraldehyde; Heart valves; Tissue valves

Indexed keywords

ALDEHYDES; CONTROLLED DRUG DELIVERY; CROSSLINKING; HEART VALVE PROSTHESES; TISSUE; VISCOELASTICITY;

BIOPROSTHESES; DRUG DELIVERY MATRICES; GLUTARALDEHYDE; TISSUE HEART VALVES;

BIOMATERIALS;

COLLAGEN; GLUTARALDEHYDE;

BIOCOMPATIBILITY; BIODEGRADATION; BLOOD VESSEL GRAFT; CROSS LINKING; CYTOTOXICITY; DRUG DELIVERY SYSTEM; HEART VALVE PROSTHESIS; PRIORITY JOURNAL; PROSTHESIS FIXATION; REVIEW; TENDON GRAFT;

EID: 0030111405     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/0142-9612(96)82721-9     Document Type: Review

References (169)

1. Hopwood D. Theoretical and practical aspects of glutaraldehyde fixation. Histochem J 1972; 4: 267-303.
2. Monsan P, Puzo G, Mazarguil H. Mechanism of glutaraldehyde protein bond formation. Biochemie 1975; 57: 1281-1292.
3. Rasmussen KE, Albrechtsen J. Glutaraldehyde: influence of pH, temperature and buffering on the polymerization rate. Histochemistry 1974; 38: 19-26.
4. Fein ML, Filachione EM. Tanning studies with aldehydes. J Am Leather Chem Assoc 1957; 52: 17-23.
5. Fein ML, Harris EH Jr, Naghski J, Filachione EM. Tanning with glutaraldehyde. I. Rate studies. J Leather Chem Assoc 1959; 54: 488-502.
6. Bowers JH, Cater CW. Crosslinking of collagen. J Appl Chem 1964; 14: 296-304.
7. Bowers JH, Cater CW. The reaction of glutaraldehyde with proteins and other biological materials. J Microsc Soc 1966; 85: 193-200.
8. Bruck SD. Properties of Biomaterials in the Physiological Environment. Boca Raton, FL: CRC Press, 1980: 113-130.
9. Korn AH, Peairheller SH, Filachione EM. Glutaraldehyde: nature of the reagent. J Molec Biol 1972; 65: 525-529.
10. Whipple E, Buta M. Structure of aqueous glutaraldehyde. J Org Chem 1974; 39: 1666-1668.
11. Grant M, Prockop D. Medical progress: the biosynthesis of collagen. New Engl J Med 1972; 286: 194-199.
12. Anderson PJ. Purification and quantitation of glutaraldehyde and its effect on several enzyme activities in skeletal muscle. J Histochem Cytochem 1967; 15: 652-661.
13. Blauer G, Harmatz E, Meir D, Swenson MK, Zvilichowsky B. The interaction of glutaraldehyde with poly(alpha-L-lysine), N-butyl amine and collagen. I. The primary photon release in aqueous media. Biophysics 1975; 14: 2585-2598.
14. Rembaum A, Levy J, Gupta A, Margel S. Reaction of polyglutaraldehyde with proteins. Polym Prepr Am Chem Soc Div Polym 1978; 19: 648-650.
15. Leefrak EA, Star A. Cardiac Valve Prostheses. New York: Appleton-Century-Crofts, 1979: 273.
16. William WA, Judith DA, Jon CK. In: Ionescu MI, ed. Tissue Heart Valves. London: Butterworths, 1979, pp. 89-126.
17. Matloff JM, ed. Cardiac Valve Replacement: Current Status. Boston: Martinus Nijhoff, 1985.
18. Starek PJK, ed. Heart Valve Replacement and Reconstruction. Chicago: Year Book Medical Publishers, 1987.
19. Jamieson WR, Gerein AN, Tyers GF et al. Carpentier-Edwards supra-annular porcine bioprosthesis. Clinical experience and implantation characteristics. J Thorac Cardiovasc Surg 1986; 91: 555-565.
20. Rupprath G, Thuer D, Vogt J et al. The durability of bioprostheses in young people. Long term results with intra- or extracardiac implanted porcine valves. J Cardiovasc Surg (Torino) 1985; 26: 251-257.
21. Milano AD, Bortolotti U, Mazzucco A, Guerra F, Magna A, Gallucci V. Aortic valve replacement with Hancock standard, Bjork-Shiley and Lillehei-Kaster prostheses. A comparison based on follow-up from 1 to 15 years. J Thorac Cardiovasc Surg 1989; 98: 37-17.
22. Kazui T, Morikawa M, Nakanishi K et al. Long-term results of mitral valve replacement using glutaraldehyde treated porcine bioprostheses - Comparison of the Hancock and Liotta valves. Nippon Kyobu Geka Gakkai Zasshi 1990; 6: 1023-1029.
23. Jamieson WR, Miyagishima RT, Munro AI et al. The Carpentier-Edwards supra-annular porcine bioprostheses: clinical performance to 8 years of a new generation of a porcine bioprosthesis. J Cardiac Surg 1991; 6: 562-567.
24. Valente M, Minarini M, lus P et al. Durability of glutaraldehyde-fixed pericardial valve prostheses: clinical and animal experimental studies. J Heart Valve Dis 1992; 2: 216-224.
25. Kawachi Y, Tominaga R, Hisahara M, Nakshima A, Yasui H, Tokunaga K. Excellent durability of the Hancock porcine bioprostheses in the tricuspid position. A 16-year follow-up study. J Thorac Cardiovasc Surg 1992; 104: 1561-1566.
26. Bruck SD, Possible causes for the calcification of glutaraldehyde treated tissue heart valves and blood contacting elastomers during prolonged use in medical devices: a physico-chemical view. Biomaterials 1981; 2: 14-18.
27. Ashraf M, Blood CM. Structural alterations of the porcine heterograft after various durations of implantation. Am J Cardiol 1978; 41: 1185-1190.
28. Woodroof EA. In: Ionescu MI, ed. Tissue Heart Valves. London: Butterworths, 1979: 347-362.
29. Ferrans VJ, Boyce SW, Billingham ME, Spray TL, Robert WC. Infection of glutaraldehyde-preserved porcine valves heterograft. Am J Cardiol 1979; 43: 1123-1126.
30. Broom ND. The stress-strain and fatigue behaviour of glutaraldehyde preserved heart valve tissue. J Biomech 1977; 10: 707-724.
31. Broom ND, Thomson FJ. Influence of fixation conditions on the performance of glutaraldehyde-treated porcine aortic valves: towards a more scientific basis. Thorax 1979; 34: 166-176.
32. Song T, Vesely I, Boughner D. Effects of dynamic fixation on shear behaviour of porcine xenograft valves. Biomaterials 1990; 11: 191-196.
33. Vesely I, Gonzalez-Lavin L, Graf D, Boughner D. Mechanical testing of cryopreserved aortic allografts. Comparison with xenografts and fresh tissue. J Thorac Cardiovasc Surg 1990; 99: 119-123.
34. Pereira CA, Lee JM, Haberer SA. Effect of alternative crosslinking methods on the low strain rate viscoelastic properties of bovine pericardial bioprosthetic material. J Biomed Mater Res 1990; 24: 345-361.
35. Trowbridge EA, Crofts CE. The tearing strength of glutaraldehyde fixed bovine pericardium. Biomater Artif Cells Artif Organs 1989; 17: 315-328.
36. Lee JM, Corrente R, Haberer SA. The bovine pericardial xenografts: II. Effect of tethering or pressurization during fixation on the tensile viscoelastic properties of bovine pericardium. J Biomed Mater Res 1989; 23: 477-489.
37. Lee JM, Ku M, Haberrer SA. The bovine pericardial xenograft: III. Effect on uniaxial and sequential biaxial stress during fixation on the tensile viscoelastic properties of bovine pericardium. J Biomed Mater Res 1989; 23: 491-506.
38. Crofts CE, Trowbridge EA. Local variation in the tearing strength of chemically modified pericardium. Biomaterials 1989; 10: 230-234.
39. Christie GW. Anatomy of aortic heart valve leaflets: the influence of glutaraldehyde fixation on function. Eur J Cardiothorac Surg 1992; 6: 525-532.
40. Barratt-Boyes BG. Clinical experience with zero-pressure-fixed Medtronic Intact bioprosthetic valve. Eur J Cardiothorac Surg 1992; 6: 579-581.
41. Jamieson WR, Munro AI, Miyagishima RT et al. The Carpentier-Edwards supra-annular porcine bioprosthesis: new generation low pressure glutaraldehyde fixed prosthesis. J Cardiac Surg 1988; 3: 507-521.
42. Barratt-Boyes BG, Jaffe WM, Ko PH, Whitlock RM. The zero pressure Medtronic Intact porcine valve: an 8.5 year review. J Heart Valve Dis 1993; 2: 604-611.
43. Schoen FJ, Tsao JW, Levy RJ. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms for bioprosthetic tissue mineralization. Am J Pathol 1986; 123: 134-145.
44. Moritz A, Grimm M, Eybl E et al. Improved spontaneous endothelialization by postfixation treatment of bovine pericardium. Eur J Cardiothorac Surg 1991; 5: 155-159.
45. Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1983; 113: 143-155.
46. Golomb G, Schoen FJ, Smith MS, Linden J, Nixon M, Levy RJ. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol 1987; 127: 122-130.
47. Schoen FJ, Levy RJ. Calcification of bioprosthetic heart valves. In: Bodnar E, Frater RWM, eds. Replacement Cardiac Valves. Elmsford, NY: Pergamon Press, 1991: 125-148.
48. Grimm M, Grabenwoger M, Eybl E et al. Improved biocompatibility of bioprosthetic heart valves by L-glutamic acid treatment. J Cardiac Surg 1992; 7: 58-64.
49. Ferrans VJ, Hilbert SL, Jones M. Biomaterials. In: Bodnar E, Frater RWM, eds. Replacement Cardiac Valves. Elmsford, NY: Pergamon Press, 1991: 49-76.
50. Imamura E, Sawatani O, Koyanagi H, Noishiki Y, Miyata T. Epoxy compounds as a new cross-linking agent for porcine aortic leaflets: subcutaneous implantation studies in rats. J Cardiac Surg 1989; 4: 50-57.
51. Xi T, Liu F, Xi B. Effect of pretreatment with epoxy compounds on the mechanical properties of bovine pericardial bioprosthetic materials. J Biomater Applic 1992; 7: 61-75.
52. Kambic HE, Kantrowitz A, Sung P, eds. Vascular Graft Update: Safety and Performance. Philadelphia: ASTM, 1986.
53. Igo SR, Meador JW, Frazier OH. Comparative in vitro evaluations of vascular graft compliance during dynamic loading. Trans Am Soc Artif Intern Organs 1988; 34: 785-788.
54. Salles CA, Puig LB, Casagrande IS et al. Early experience with crimped bovine pericardial conduits for arterial reconstruction. Eur J Cardiothorac Surg 1991; 5: 273-278.
55. Wang E, Thyagarajan K, Tu R et al. Evaluation of collagen modification and surface properties of a bovine artery via polyepoxy compound fixation. Int J Artif Organs 1993; 16: 530-536.
56. Tu R, Quijano RC, Lu CL et al. A preliminary study of the fixation mechanism of collagen reaction with a polyepoxy fixative. Int J Artif Organs 1993; 16: 537-544.
57. Burns P, Edwards GA, Roberts GR, Ketharanathan V, Hatami-Monazah H. Performance of a new vascular xeno prosthesis. Trans Am Soc Artif Intern Organs 1989; 35: 214-218.
58. Batteisti G, Stio F, Marigliani M. The biosynthetic omniflow prosthesis: preliminary experience. Ann Ital Chir 1989; 60: 431-433.
59. Roberts AH, Wee JT, Nightingale G, Macleod AM, O'Brien BM. Glutaraldehyde-tanned microvascular grafts. Br J Plast Surg 1989; 42: 429-434.
60. Hamilton G, Megerman J, L'Italien GJ et al. Prediction of aneurysm formation in vascular grafts of biologic origin. J Vasc Surg 1988; 7: 400-408.
61. Tomizawa Y, Noishiki Y, Okoshi T, Koyanagi H. Development of a small-calibre vascular graft with antithrombogenicity induced by extreme hydrophilicity. Trans Am Soc Artif Intern Organs 1988; 34: 644-650.
62. Dardik H, Miller N, Dardik A et al. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. J Vasc Surg 1988; 7: 336-346.
63. Abbott WM, Megerman J, Hasson JE, L'Italien G, Warnock DF. Effect of compliance mismatch on vascular graft patency. J Vasc Surg 1987; 5: 376-382.
64. Sawyer PN, Fitzgerald J, Kaplitt MJ et al. Ten year experience with the negatively charged glutaraldehyde-tanned vascular graft in peripheral vascular surgery. Initial multi center trial. Am J Surg 1987; 154: 533-537.
65. Moritz A, Grimm M, Eybl E et al. Improved endothelialization of postfixation treated biological vascular grafts. Int J Artif Organs 1992; 15: 289-294.
66. Greisler HP. New Biological and Synthetic Vascular Prostheses. Austin, TX: RG Landes, 1991: 25.
67. Kottke-Marchant K, Anderson JM, Umemura Y, Marchant RE. Effect of albumin coating on the in vitro blood compatibility of Dacron arterial prostheses. Biomaterials 1989; 10: 147-155.
68. Guidoin R, King MW, Awad J et al. Albumin coated and critical point dried polyester prostheses as substitutes in the thoracic aorta of dogs. Trans Am Soc Artif Intern Organs 1983; 29: 290-295.
69. Mehri Y, Roy R, Guidoin R, Hebert J, Mourad W, Ben Slimane S. Cellular reactions to polyester arterial prostheses impregnated with cross-linked albumin: in vivo studies in mice. Biomaterials 1989; 10: 56-58.
70. Ben Slimane S, Guidoin R, Merhi Y, King MW, Domurado D, Sigot-Luizard MF. In vivo evaluation of polyester arterial grafts coated with albumin: the role and importance of cross-linking agents. Eur Surg Res 1988; 20: 66-74.
71. Jonas RA, Ziemer G, Schoen FJ, Britton L, Castaneda AR. A new sealant for knitted Dacron prostheses: minimally cross-linked gelatin. J Vasc Surg 1988; 7: 414-419.
72. Guidoin R, Marceau D, Couture J et al. Collagen coatings as biological sealants for textile arterial prostheses. Biomaterials 1989; 10: 156-165.
73. McMaster WC, Kouzelos J, Laddle S, Waugh TR. Tendon grafting with glutaraldehyde fixed material. J Biomed Mater Res 1976; 10: 259-271.
74. Allen PR, Amis AA, Jones MM, Heatley FW. Evaluation of preserved bovine tendon xenografts: a histological, biomechanical and clinical study. Biomaterials 1987; 8: 146-152.
75. Chvapil M, Gibeault D, Wang TF. Use of chemically purified and cross-linked bovine pericardium as a ligament substitute. J Biomed Mater Res 1987; 21: 1383-1393.
76. Smith DJ, Jones CS, Hull M, Kleinert HE. Evaluation of glutaraldehyde-treated tendon xenograft. J Hand Surg 1986; 11: 97-106.
77. Smith DJ, Jones CS, Hull M, Robson MC, Kleinert HE. Bioprosthesis in hand surgery. J Surg Res 1986; 41: 378-387.
78. Kato YP, Dunn MG, Zawadsky JP, Tria AJ, Silver FH. Regeneration of Achilles tendon with a collagen tendon prosthesis. Results of a one year implantation study. J Bone Joint Surg (Am) 1991; 73: 561-574.
79. Hsu SY, Cheng JC, Chong YW, Leung PC. Glutaraldehyde-treated bioprosthetic substitute for rabbit Achilles tendon. Biomaterials 1989; 10: 258-264.
80. Cheng JC, Hsu SY, Chong YW, Leung PC. Use of bioprosthetic tendon in digital pulley reconstruction -an experimental study. J Hand Surg (Br) 1986; 11: 225-230.
81. Segesser L, Cox J, Faidutti B. Equine pericardial xenografts in orthotopic position: early results. Thorac Cardiovasc Surg 1986; 34: 35-38.
82. Gallo I, Artinano E, Duran CG. Late clinical results with the use of heterologous pericardium for closure of the pericardial cavity. J Thorac Cardiovasc Surg 1985; 89: 709-712.
83. Heydorn WH, Daniel JS, Wade CE. A new look at pericardial substitutes. J Thorac Cardiovasc Surg 1987; 94: 291-296.
84. Haluck RS, Richenbacher WE, Myers JL, Miller CA, Wise RK, Waldhausen JA. Pericardium as a thoracic aortic patch: glutaraldehyde-fixed and fresh autologous pericardium. J Surg Res 1990; 6: 611-614.
85. Aleksi-Meskhishvili W, Nikoliuk AP, Popov SA et al. Repair of ventricular septal defects with pericardial xenografts in infants. Khirurgiia 1991; 8: 93-97.
86. Opie JC, Larrieu AJ, Cornell IS. Pericardial substitutes: delayed reexploration and findings. Ann Thorac Surg 1987; 43: 383-385.
87. Okoshi T, Noishiki Y, Tomizawa Y, Morishima M, Koyanagi H. Development of an antithrombogenic cardiac wall substitute which can be reconstructed by infiltration of host cells. Trans Am Soc Artif Intern Organs 1988; 34: 532-537.
88. Xu BZ, Pan HX, Li KM et al. Study and clinical application of a porcine biomembrane for the repair of dural defects. J Neurosurg 1988; 69: 707-711.
89. Wisnewski PJ, Powers DL, Kennedy JM. Glutaraldehyde-cross-linked meniscal allografts: mechanical properties. J Invest Surg 1988; 4: 259-266.
90. Strother M, Laravuso R, Rappe A, Su SL, Northern K. Glutaraldehyde cross-linked collagen: a new material for therapeutic embolisation. Am J Neuroradiol 1987; 8: 509-515.
91. Park GB. Burn wound covering: a review. Biomater Med Dev Artif Organs 1978; 6: 1-35.
92. Chvapil M. Considerations on manufacturing principles of a synthetic burn dressing: a review. J Biomed Mater Res 1982; 16: 245-263.
93. Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 1980; 14: 107-131.
94. Boyce ST, Christianson DJ, Hansbrough JF. Structure of collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. J Biomed Mater Res 1988; 22: 939-957.
95. Morimoto Y, Fujimoto S. Albumin microspheres as drug carriers. CRC Crit Rev Ther Drug Carrier Syst 1983; 2: 18-63.
96. Gupta PK, Hung CT. Albumin microspheres. I. Physico-chemical characteristics. J Microencaps 1989; 6: 427-461.
97. Gupta PK, Hung CT. Albumin microspheres. II. Applications in drug delivery. J Microencaps 1989; 6: 463-472.
98. Arshady R. Albumin microspheres and microcapsules: methodology of manufacturing techniques. J Contr Rel 1990; 14: 111-131.
99. Longo EW, Goldberg EP. Hydrophilic albumin microspheres. Meth Enzymol 1985; 112: 18-26.
100. Longo EW, Iwata H, Lindheimer TA, Goldberg EP. Preparation of hydrophilic albumin microspheres using polymeric dispersing agents. J Pharm Sci 1982; 71: 1323-1328.
101. Chen Y, Willmott N, Anderson J, Florence AT. Comparison of albumin and casein microspheres as a carrier for doxorubicin. J Pharm Pharmacol 1987; 39: 978-985.
102. Willmott N, Magee GA, Cummings J, Halbert GW, Smyth JF. Doxorubicin loaded casein microspheres: protean nature of drug incorporation. J Pharm Pharmacol 1992; 44: 472-475.
103. Willmott N, Chen Y, Goldberg J, McArdle C, Florence AT. Biodegradation of embolized protein microspheres in the lung, liver and kidney of rats. J Pharm Pharmacol 1989; 41: 433-438.
104. Jayakrishnan A, Knepp WA, Quigg JM, Sitren HS, Bagnall JJ, Goldberg EP. Casein microspheres: preparation and evaluation as a carrier for controlled drug delivery. Int J Pharm 1994; 106: 221-228.
105. Knepp WA, Jayakrishnan A, Goldberg EP. Synthesis, properties and intratumoral evaluation of mitoxantrone loaded casein microspheres in Lewis lung carcinoma. J Pharm Pharmacol 1993; 45: 887-891.
106. Latha MS, Jayakrishnan A. Glutaraldehyde cross-linked bovine casein microspheres as a matrix for the controlled release of theophylline: in vitro studies. J Pharm Pharmacol 1994; 46: 8-13.
107. Latha MS, Jayakrishnan A. A new method for the synthesis of smooth, round, hydrophilic protein microspheres using low concentrations of polymeric dispersing agents. J Microencaps 1995; 12: 7-12.
108. Latha MS, Jayakrishnan A, Rathinam K, Mohanty M. Casein as a carrier matrix for 5-fluorouracil: drug release from microspheres, drug-protein conjugates and in vivo degradation of microspheres in rat muscle. J Pharm Pharmacol 1994; 46: 858-862.
109. Latha MS, Rathinam K, Mohanan V, Jayakrishnan A. Bioavailability of theophylline from glutaraldehyde cross-linked casein microspheres in rabbits following oral administration. J Contr Rel 1995; 34: 1-7.
110. Narayani R, Rao KP. Controlled release of anti-cancer drug methotrexate from biodegradable gelatin microspheres. J Microencaps 1994; 11: 69-77.
111. Yan CH, Li XW, Chen XL et al. Anti-cancer gelatin microspheres with multiple functions. Biomaterials 1991; 12: 640-644.
112. Tabata Y, Ikada Y. Synthesis of gelatin microspheres containing interferon. Pharm Res 1989; 6: 422-427.
113. Oner L, Groves MJ. Optimization of conditions for preparing 2-5 micron range gelatin microparticles by using chilled dehydration agents. Pharm Res 1993; 10: 621-626.
114. Wissemann KW, Jacobson BS. Pure gelatin microcarriers: synthesis and use in cell attachment and growth of fibroblasts and endothelial cells. In Vitro Cell Dev Biol 1985; 21: 391-401.
115. Thanoo BC, Sunny MC, Jayakrishnan A. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J Pharm Pharmacol 1992; 44: 283-286.
116. Jameela SR, Misra A, Jayakrishnan A. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. J Biomat Sci Polym Ed 1994; 6: 621-632.
117. Jameela SR, Jayakrishnan A. Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. Biomaterials 1995; 16: 769-775.
118. Thanoo BC, Sunny MC, Jayakrishnan A. Controlled release of oral drugs from cross-linked poly(vinyl alcohol) microspheres. J Pharm Pharmacol 1993; 46: 16-20.
119. Thanoo BC, Sunny MC, Jayakrishnan A. Preparation and properties of barium sulphate and methyl iothalamate loaded poly(vinyl alcohol) microspheres as particulate emboli. J Appl Biomater 1991; 2: 67-72.
120. Bhargava K, Ando HY. Immobilization of active urokinase on albumin microspheres: use of a chemical dehydrant and process monitoring. Pharm Res 1992; 9: 776-781.
121. Yan CH, Kitano H, Ise N. Functional properties of proteins immobilized on albumin microspheres. Biotechnol Appl Biochem 1988; 10: 13-20.
122. Bajpai PK. Immunological aspects of treated natural tissue prostheses. In: Williams DF, ed. Biocompatibility of Tissue Analogues. Boca Raton, FL: CRC Press, 1985: 5-25.
123. Magilligan DJ, Lewis JW Jr, Heinzerlng RH, Smith D. Fate of a second porcine bioprosthetic valve. J Thorac Cardiovasc Surg 1983; 85: 362-370.
124. Slanczka DJ, Russo DA, Bajpai PK, Woodroof EA. Immunogenicity of tanned tissue used in heart valve replacement. Proc 7th New Engl Bioengng Conf 1979; 197-200.
125. Bajpai PK, Russo DA, Slanczka DJ, Weiskettel KE. Immunogenicity of glutaraldehyde treated tissue used in heart valve replacement. In: Winter GD, Gibbson DF, Plenk H, eds. Advances in Biomaterials. Chichester: Wiley, 1982: 603-612.
126. Nimni ME, Cheung D, Strates B, Kodama M, Sheikh K. Chemically modified collagen: a natural biomaterial for tissue replacement. J Biomed Mater Res 1987; 21: 741-771.
127. Oliver RF, Grant RA, Kent CM. The fate of cutaneously and subcutaneously implanted trypsin purified dermal collagen in the pig. Br J Exp Pathol 1972; 53: 540-549.
128. Oliver RF, Grant RA, Cox RW, Hulme MJ, Mudie A. Histological studies of subcutaneous and intraperitoneal implants of trypsin-prepared dermal collagen allografts in the rat. Clin Orthop Rel Res 1976; 115: 291-302.
129. Chvapil M, Owen JA, Clark DS. Effect of collagen crosslinking on the rate of resorption of implanted collagen tubings in rabbits. J Biomed Mater Res 1977; 11: 297-314.
130. Speer DP, Chvapil M, Eskelson CD, Ulreich J. Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials. J Biomed Mater Res 1980; 14: 753-764.
131. Ketharnathan V, Christie VA. Glutaraldehyde tanned ovine collagen conduits as vascular xenografts in dogs. Arch Surg 1980; 115: 967-969.
132. Cooke A, Oliver RF, Edward M. An in vivo cytotoxicity study of aldehyde-treated pig dermal collagen. Br J Pathol 1983; 64: 172-176.
133. McPherson JM, Sawamura S, Armstrong R. An examination of the biologic response to injectable, glutaraldehyde crosslinked collagen implants. J Biomed Mater Res 1986; 20: 93-107.
134. Chvapil M, Speer D, Mora W, Eskelson C. Effect of tanning agent on tissue reaction to implanted collagen sponge. J Surg Res 1983; 35: 402-409.
135. Makkes PC, Thoden van Velzen SK, van den Hoff A. Short term tissue reaction to enclosed glutaraldehyde fixed tissue. Oral Surg 1978; 46: 854-861.
136. McMaster WC, Kouzelos J, Laddle S, Waugh TR. Tendon grafting with glutaraldehyde fixed material. J Biomed Mater Res 1976; 10: 259-271.
137. Ulreich JB, Chvapil M. A quantitative microassay for in vitro toxicity testing of biomaterials. J Biomed Mater Res 1981; 15: 913-922.
138. Ishihara T, Ferrans VJ, Jones M, Boyce SW, Roberts WC. Occurrence and significance of endothelial cells in implanted porcine bioprosthetic valves. Am J Cardiol 1981; 48: 443-454.
139. Quteish D, Singh G, Dolby AE. Development and testing of a human collagen graft material. J Biomed Mater Res 1990; 24: 749-760.
140. Eybl E, Griesmacher A, Grimm M, Wolner E. Toxic effects of aldehydes released from fixed pericardium on bovine aortic endothelial cells. J Biomed Mater Res 1989; 23: 1355-1365.
141. Webb CL, Schoen FL, Levy RJ. Covalent binding of aminopropanehydroxy diphosphonate to glutaraldehyde residues in pericardial bioprosthetic tissue: stability and calcification inhibition studies. Exp Molec Pathol 1989; 50: 291-302.
142. Huang-Lee LLH, Cheung DT, Nimni ME. Biochemical changes and cytotoxicity associated with the degradation of polymeric glutaraldehyde derived crosslinks. J Biomed Mater Res 1990; 24: 1185-1201.
143. Gendler E, Gendler S, Nimni ME. Toxic reactions evoked by glutaraldehyde-fixed pericardium and cardiac valve tissue prosthesis. J Biomed Mater Res 1984; 18: 727-736.
144. Nimni ME. The crosslinking and structure modification of the collagen matrix in the design of cardiovascular prosthesis. J Cardiac Surg 1988; 3: 523-533.
145. Chvapil M. Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layer. US Patent 3,823,212, 1974.
146. Wiebe D, Megerman J, L'Italien GJ, Abbott WM. Glutaraldehyde release from vascular prostheses of biologic origin. Surgery 1988; 104: 26-33.
147. Grimm M, Eybl E, Grabenwoger M et al. Glutaraldehyde affects biocompatibility of bioprosthetic heart valves. Surgery 1992; 111: 74-78.
148. Grabenwoger M, Grimm M, Eybl E et al. Endothelial cell lining of bioprosthetic heart valve material. J Cardiac Surg 1992; 7: 79-84.
149. Grabenwoger M, Grimm M, Eybl E et al. Decreased tissue reaction to bioprosthetic heart valve material after L-glutamic acid treatment. A morphological study. J Biomed Mater Res 1992; 26: 1231-1240.
150. Hoffmann D, Gong G, Liao K, Macaluso F, Nikolic SD, Frater RW. Spontaneous host endothelial growth on bioprostheses. Influence of fixation. Circulation 1992; 86: 1175-1179.
151. van Luyn MJA, van Wachem PB, Damink LO, Dijkstra PJ, Feijen J, Nieuwenhuis P. Relations between in vitro cytotoxicity and crosslinked dermal sheep collagens. J Biomed Mater Res 1992; 26: 1091-1110.
152. van Luyn MJA, van Wachem PB, Damink LO, Dijkstra PJ, Feijen J, Nieuwenhuis P. Secondary cytotoxicity of cross-linked dermal sheep collagens during repeated exposure to human fibroblasts. Biomaterials 1992; 13: 1017-1024.
153. Ruijgrok JM, De Wijn JR. Optimising glutaraldehyde crosslinking of collagen: effects of time, temperature and concentration as measured by shrinkage temperature. J Mater Sci Mater Med 1994; 5: 80-87.
154. Reul GJ, Coley DA, Duncan JM et al. Valve failure with the Ionescu-Shiley bovine pericardial bioprostheses: analysis of 2680 patients. J Vasc Surg 1985; 2: 192-204.
155. Schoen FJ, Fernandez J, Gonzalez-Lavin L, Cernaianu A. Causes of failure of bovine pericardial bioprosthetic heart valves. J Thorac Cardiovasc Surg 1988; 96: 642-651.
156. Milano AD, Bortolotti U, Mazzucco A et al. Performance of the Hancock porcine bioprosthesis following aortic valve replacement: considerations based on a 15-year experience. Ann Thorac Surg 1988; 46: 216-222.
157. Gallo I, Nistal F, Artinano E. Six- to ten-year follow-up on patients with the Hancock cardiac prostheses. J Thorac Cardiovasc Surg 1986; 92: 14-20.
158. Gabbay S, Kadam P, Factor S, Cheung TK. Do heart valve bioprostheses degenerate for metabolic or mechanical reasons? J Thorac Cardiovasc Surg 1988; 95: 208-215.
159. Schoen FJ. Cardiac valve prostheses: review of clinical status and contemporary biomaterial issues. J Biomed Mater Res 1987; 21: 91-117.
160. Tan AJK, Holt DL. The effects of sterilisation and storage treatments on the stress-strain behaviour of aortic leaflets. Ann Thorac Surg 1976; 22: 188-194.
161. Rousseau EPM, Sauren AAHJ, van Hout MC, van Steenhoven AA. Elastic and viscoelastic behaviour of fresh and glutaraldehyde-treated porcine aortic valve tissue. J Biomech 1983; 16: 339-348.
162. Lee JM, Boughner DR, Courtman DW. The glutaraldehyde stabilized porcine aortic valve xenograft. II: Effect of fixation with or without pressure on the tensile viscoelastic properties of the leaflet material. J Biomed Mater Res 1984; 18: 79-98.
163. Trowbridge EA, Roberts KM, Crofts CE, Lawford PV. Pericardial heterografts: towards quality control of the mechanical properties of glutaraldehyde-fixed leaflets. J Thorac Cardiovasc Surg 1986; 92: 21-28.
164. Trowbridge EA, Crofts CE. The standardization of gauge length: its influence on the relative extensibility of natural and chemically modified pericardium. J Biomech 1986; 19: 1023-1033.
165. Lee JM, Haberer SA, Boughner DR. The bovine pericardial xenograft. I. Effect of fixation in aldehydes without constraint on the tensile viscoelastic properties of bovine pericardium. J Biomed Mater Res 1989; 23: 457-475.
166. Sung HW, Shen SH, Tu R et al. Comparison of the cross-linking characteristics of porcine heart valves fixed with glutaraldehyde or epoxy compounds. J Am Soc Artif Intern Organs 1993; 39: M532-536.
167. Lohre JM, Baclig L, Wickham E et al. Evaluation of epoxy ether fixed bovine arterial grafts for mutagenic potential. J Am Soc Artif Intern Organs 1993; 39: 106-130.
168. Liao KX, Seifter E, Gong GF, Yellin EL, Frater RW. Improved biocompatibility of bovine pericardium using a new method of cross-linking. Am Soc Artif Intern Organs J 1991; 37: M175-176.
169. Simmons DM, Kearney JN. Evaluation of collagen cross-linking techniques for the stabilization of tissue matrices. Biotechnol Appl Biochem 1993; 17: 23-29.